Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NSMAF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GRIN3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LOC101928778 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
VSTM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UGGT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C8orf44 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EHD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIAH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACTN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CBLN4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRPH2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UPK1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GADD45B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00313 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENKUR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on